Investor Relations

SIGA is concerned about the prevention and treatment of infectious diseases that affect people all over the world. We're very interested in your questions or comments.

SIGA has been a publicly traded company since 1997 (SIGA).


Monkeypox cases have been rising in North American as well as European countries, in addition to the endemic African countries, SIGA is monitoring the growing outbreak, and is supporting the response. Monkeypox in the News

Press Release: SIGA Announces Collaboration with Oxford University to Support Expanded Access Protocol for Use of TPOXX® (Tecovirimat) To Treat Monkeypox in Central African Republic (July 2021)

U.S. medical providers, please visit for guidance on obtaining and using TPOXX. If you are a foreign government or medical provider and have an inquiry about TPOXX (Tecovirimat-SIGA), please contact us at

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.